|
Transasia Bio-Medicals Signs An Agreement
With Grifols
Transasia Bio-Medical Ltd. has signed an agreement with
Grifols, Spain to exclusively distribute its range of instruments and reagents
in the field of transfusion medicine in the Indian market. Through this
partnership with Grifols, Spain, Transasia Bio-Medical will now offer a complete
portfolio of products in the transfusion medicine space in the Indian
market.
The new line of products that Transasia would distribute
would be WaDiana Compact®, DG Spin™, DG
Therm™ in the instruments section, DG Gel® cards
and Grifols Red Blood Cells in the reagents section. DG Gel® cards and Grifols
Red Blood Cells, which are based on Gel Test™ technology, is tomation
meets the need for ABO and Rh typing, antibody screening and identification,
compatibility testing, reverse serum grouping, and antigen typing.
(Ref: The Medical Buyer dated November 2007)
GE Healthcare's Dexa Scan To Speed Up Bone
Mineral Density Testing In Rural Areas
GE Healthcare's advanced bone mineral density scan system,
Dexa Scan, is expected to provide easy and simple diagnosis to the patients in
the far flung regions of the country. Dexa scan is based on "fan-beam" X-ray
bone densitometer technology fitted in a mobile van. It operates on Dual-Energy
X-ray Absorbtiometry and is used to measure and calculate bone, fat and muscle
mass.
Dexa scans is considered to be the 'gold standard' for
physicians to detect and diagnose skeletal diseases, including osteoporosis. It
can also perform vertebral imaging.
GE's novel mobile prodigy and other lunar technologies help
to detect low bone mass and increased risk of facture, with direct digital
technology, precision and accuracy.
"Rather than the patient driving farther for BMD and body
composition testing, we can bring these advanced healthcare technologies closer
to the patient's home," said Laura Stoltenberg, general manager, GE Healthcare's
Lunar business.
GE Lunar also will demonstrate unique technology to help
physicians measure BMD in children, as well as systems to enable licensed
medical practitioners to simultaneously assess body composition and ascertain
fat distribution in adults.
GE Lunar feature enhanced enCORE software which will allow
physicians to measure a child's bone density, fat and lean tissue mass
composition, by factoring in and trending the child's age, height and other
variables. It will enable the physician to separate out the child's growth from
other changes to the size and density of the skeleton.
In addition to the BMD assessment, a new body composition
software systems can help people and their physicians establish goals for weight
loss, exercise and diet regimes.
Lunar systems work by measuring the regional and whole body
BMD, plus lean and fat tissue mass. It calculates the derivative values that can
be displayed in user-defined statistical formats.
The body composition values are useful to licensed medical
practitioners in their management of diseases and conditions. However the option
does not diagnose a disease, or recommend treatment regiments, or quantify
treatment effectiveness. Only the licensed medical practitioner can make these
judgments. Some of the diseases or conditions for which body or conditions for
which body composition values are useful include chronic renal failure, anorexia
nervosa, obesity, AIDS/HIV and cystic fibrosis.
Lunar iDXA software also gives physicians dedicated
reporting for body composition measurements and high percentage color fat
mapping. Patients can easily follow the report divided into three compartments:
lean mass, total body tissue percent fat, and bone density.
(Ref: The Chronicle Pharmabiz dated November 29, 2007)
|
